WallStreetZenWallStreetZen

NASDAQ: ENLV
Enlivex Therapeutics Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ENLV

Based on 2 analysts offering 12 month price targets for Enlivex Therapeutics Ltd

Min Forecast
$7.00+677.78%
Avg Forecast
$10.00+1,011.11%
Max Forecast
$13.00+1,344.44%

Should I buy or sell ENLV stock?

Based on 2 analysts offering ratings for Enlivex Therapeutics Ltd.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ENLV stock forecasts and price targets.

ENLV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-21
lockedlocked$00.00+00.00%2025-03-24

1 of 1

Forecast return on equity

Is ENLV forecast to generate an efficient return?

Company
N/A
Industry
29.26%
Market
56.76%

Forecast return on assets

Is ENLV forecast to generate an efficient return on assets?

Company
N/A
Industry
10.9%

ENLV earnings per share forecast

What is ENLV's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.59

ENLV vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ENLV$0.90$10.00+1,011.11%Strong Buy
LSTA$2.50N/AN/A
BIVI$1.14N/AN/A
SLGL$7.52N/AN/A
BLRX$4.69$19.00+305.12%Strong Buy
View Top Biotech Stocks

Enlivex Therapeutics Stock Forecast FAQ

Is Enlivex Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ENLV) stock is to Strong Buy ENLV stock.

Out of 2 analysts, 1 (50%) are recommending ENLV as a Strong Buy, 1 (50%) are recommending ENLV as a Buy, 0 (0%) are recommending ENLV as a Hold, 0 (0%) are recommending ENLV as a Sell, and 0 (0%) are recommending ENLV as a Strong Sell.

If you're new to stock investing, here's how to buy Enlivex Therapeutics stock.

What is ENLV's earnings growth forecast for 2025-2025?

(NASDAQ: ENLV) Enlivex Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 22.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 57.17%.

Enlivex Therapeutics's earnings in 2025 is -$14,326,000.

In 2025, ENLV is forecast to generate -$14,071,462 in earnings, with the lowest earnings forecast at -$14,071,462 and the highest earnings forecast at -$14,071,462.

What is ENLV's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: ENLV) forecast ROE is N/A, which is considered weak.

What is ENLV's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ENLV price target, the average ENLV price target is $10.00, with the highest ENLV stock price forecast at $13.00 and the lowest ENLV stock price forecast at $7.00.

On average, Wall Street analysts predict that Enlivex Therapeutics's share price could reach $10.00 by Apr 21, 2026. The average Enlivex Therapeutics stock price prediction forecasts a potential upside of 1,011.11% from the current ENLV share price of $0.90.

What is ENLV's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: ENLV) Enlivex Therapeutics's current Earnings Per Share (EPS) is -$0.66. In 2025, ENLV's EPS is forecast to hit -$0.59 (min: -$0.59, max: -$0.59).

What is ENLV's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: ENLV) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 10.9%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.